WinstonWınston
Fractyl Health logo

Fractyl Health

GUTS
Biotechnology · Healthcare
Price
$0.81
-0.04 (-5.19%)
Market Cap
$58.5M
Exchange
NASDAQ
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+59.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 47.6M (2021) → 75.8M (2025)

Fractyl Health is a small biotech company focused on treating type 2 diabetes and metabolic diseases. Its main product is Revita, a minimally invasive procedure that uses heat to resurface the lining of the small intestine, aiming to improve how the body controls blood sugar. The company targets patients with type 2 diabetes and works with hospitals and physicians in the healthcare system.

Fractyl Health makes money by developing and eventually selling its medical procedure and related technology, though it is still in the clinical trial stage and has not yet generated meaningful revenue. The company is based in the United States and is very small, with a market cap around $100 million. Because it has no approved product yet, it burns through cash while funding research, which is the central risk — it must prove Revita works well enough to win regulatory approval before it runs out of money to operate.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

+112.2% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$75M/ year

Rising (+6% vs prior year)

R&D investment increasing — building for the future

Insider Activity

59.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~8 months

$63M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Fractyl Health has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
Data not available
Operating Margin
N/A
Data not available
ROCE
-25.3%
Weak — -25.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-100.0%
Shrinking sales (-100.0% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
2.84
Heavy debt load (2.84)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial